Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro’s superiority over standard therapy alone1,2Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

Lupus continues to carry a heavy burden despite advances in immunosuppressive therapy warranting complementary care ...

Positive recommendation based on phase II NOBILITY and phase III REGENCY data showing Gazyva/Gazyvaro's superiority over standard therapy alone1,2 Gazyva/Gazyvaro is the only anti-CD20 antibody to ...

When Selena Gomez revealed she had undergone a kidney transplant, fans were stunned. The singer and actor, known for being ...

Investigators employed the Accelerating Medicines Partnership to identify noninvasive biomarkers of lupus nephritis pathology and treatment response.

Greater disease activity and higher proteinuria levels were associated with a greater risk for VTE among patients with LN.

Real-world Effectiveness and Usage of Voclosporin: Data from the ENLIGHT-LN Registry Presenting Author: Leanna Wise, M.D., ...

Sana Biotechnology, Inc. is a Strong Buy with promising cell therapies for diabetes & B-cell disorders. Click here to find ...

The ORIGIN Phase 3 trial met the primary endpoint with a statistically significant and clinically meaningful reduction in proteinuria at week 36, in the prespecified interim analysis. Across the ...

The donation came from the David Koch Jr. Foundation to enable researchers at Stanford to redefine treatment for pediatric ...